Egetis Therapeutics AB
SE0015193305 · Outside a trading venue
2 directors and managers of Egetis Therapeutics AB have disclosed 5 transactions under MAR Article 19: 5 buys worth €63k and 0 sells worth €0, which reads as net buying. The most recent disclosed transaction was on 2021-07-08. The largest buy was PharmaExec Consulting AB (Chairman of the Board of Directors) for €43k. See live cluster buys or start a free 14-day trial to get alerts when Egetis Therapeutics AB insiders trade.
Insiders
2
Net flow
€63k
Bought
€63k
Sold
€0
Buy Egetis Therapeutics AB
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
All disclosed transactions
| Date | Type | Insider | Shares | Price | Value |
|---|---|---|---|---|---|
| 2021-07-08 5y ago | BUY | Nicklas Westerholm Chief Executive Officer (CEO)/Managing Directory | 11,000 | €0.50 | €5k |
| 2021-05-24 5y ago | BUY | PharmaExec Consulting AB Chairman of the Board of Directors | 18,237 | €0.52 | €10k |
| 2021-05-20 5y ago | BUY | PharmaExec Consulting AB Chairman of the Board of Directors | 81,763 | €0.52 | €43k |
| 2021-05-14 5y ago | BUY | Nicklas Westerholm Chief Executive Officer (CEO)/Managing Directory | 3,950 | €0.51 | €2k |
| 2021-05-12 5y ago | BUY | Nicklas Westerholm Chief Executive Officer (CEO)/Managing Directory | 6,340 | €0.51 | €3k |